Loading...

Apellis Pharmaceuticals, Inc.

APLS•NASDAQ
Healthcare
Biotechnology
$19.59
$-0.50(-2.49%)

Apellis Pharmaceuticals, Inc. (APLS) Stock Chart & Performance Analysis

Explore Apellis Pharmaceuticals, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.18%
5-Day Change
-17.59%
1-Month Change
-25.26%
3-Month Change
-31.52%
6-Month Change
-29.55%
Year-to-Date (YTD) Change
-43.34%
1-Year Change
-66.94%
3-Year Change
-64.83%
5-Year Change
-33.16%
All-Time (Max) Change
33.93%

Analyzing Apellis Pharmaceuticals, Inc. (APLS) Trends Across Multiple Time Frames

Apellis Pharmaceuticals, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Apellis Pharmaceuticals, Inc. stock shows -4.18% 1-day change, indicating low volatility, while its 5-day change of -17.59% suggests a broader trend. Over a 1-month period, a -25.26% drop could signal a pullback, whereas a 3-month decline of -31.52% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -29.55% and a YTD drop of -43.34% might concern investors, but a 1-year loss of -66.94% and a 3-year drop of -64.83% could indicate resilience. The 5-year surge of -33.16% highlights weak historical growth, while the all-time return of 33.93% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;